Patents Assigned to Agennix Incorporated
  • Lactoferrin compositions and methods of wound treatment
    Patent number: 8247373
    Abstract: The present invention relates to lactoferrin compositions and methods of using the compositions to treat wounds. The compositions can be administered alone or in combination with other standard wound healing therapies.
    Type: Grant
    Filed: September 8, 2011
    Date of Patent: August 21, 2012
    Assignee: Agennix Incorporated
    Inventors: Jose Engelmayer, Atul Varadhachary
  • Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
    Patent number: 8242079
    Abstract: The present invention relates to methods of treating a hyperproliferative disease by administering a composition of lactoferrin alone or in combination with standard anti-cancer therapies.
    Type: Grant
    Filed: December 9, 2010
    Date of Patent: August 14, 2012
    Assignee: Agennix Incorporated
    Inventors: Atul Varadhachary, Rick Barsky, Federica Pericle, Karel Petrak, Yenyun Wang
  • Lactoferrin as an adjuvant in cancer vaccines
    Patent number: 8105615
    Abstract: The present invention relates to methods of treating cancer by administering a composition of lactoferrin (LF) in combination with cancer vaccines.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: January 31, 2012
    Assignee: Agennix Incorporated
    Inventors: Atul Varadhachary, Federica Pericle
  • Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
    Patent number: 8058234
    Abstract: The present invention relates to methods of using lactoferrin (LF) to treat, prevent or reduce the incidence of organ transplant rejection and graft-versus-host-disease. More particularly, the present invention relates to methods of reducing an immune response against miss-matched transplanted organs such as kidney, heart, lung, liver, pancreas and stem cells by administering a composition of lactoferrin to the recipient patients. In addition, this invention relates to the treatment of bone marrow transplant (BMT) donors with lactoferrin to attenuate the development of graft-versus-host-disease in the recipients. Moreover, this invention relates to the treatment of xenograft organ donors with lactoferrin to attenuate the development of graft rejection in the recipients.
    Type: Grant
    Filed: August 17, 2009
    Date of Patent: November 15, 2011
    Assignee: Agennix Incorporated
    Inventors: Atul Varadhachary, Federica Pericle
  • Lactoferrin compositions and methods of wound treatment
    Patent number: 8030272
    Abstract: The present invention relates to lactoferrin compositions and methods of using the compositions to treat wounds. The compositions can be administered alone or in combination with other standard wound healing therapies.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: October 4, 2011
    Assignee: Agennix Incorporated
    Inventors: Jose Engelmayer, Atul Varadhachary
  • Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
    Patent number: 7901879
    Abstract: The present invention relates to methods of treating a hyperproliferative disease by administering a composition of lactoferrin alone or in combination with standard anti-cancer therapies.
    Type: Grant
    Filed: May 9, 2003
    Date of Patent: March 8, 2011
    Assignee: Agennix Incorporated
    Inventors: Atul Varadhachary, Rick Barsky, Federica Pericle, Karel Petrak, Yenyun Wang
  • LACTOFERRIN AS A RADIOPROTECTIVE AGENT
    Publication number: 20100215699
    Abstract: This present invention relates to the field of protecting against, or rectifying the effects of damaging ionizing irradiation. The method of treatment involves oral administration of a lactoferrin composition, alone or in combination with other treatments, both in combination with other radio-protective agents and/or the standard of care. Further, the method of treatment provides for a topical administration of lactoferrin to treat lesions caused by local damaging irradiation.
    Type: Application
    Filed: June 22, 2007
    Publication date: August 26, 2010
    Applicant: AGENNIX INCORPORATED
    Inventors: Atul Varadhachary, Karel Petrak, Paul Blezinger
  • LACTOFERRIN COMPOSITIONS AND METHODS OF WOUND TREATMENT
    Publication number: 20090253627
    Abstract: The present invention relates to lactoferrin compositions and methods of using the compositions to treat wounds. The compositions can be administered alone or in combination with other standard wound healing therapies.
    Type: Application
    Filed: March 12, 2009
    Publication date: October 8, 2009
    Applicant: AGENNIX INCORPORATED
    Inventors: Jose Engelmayer, Atul Varadhachary
  • COMPOSITION OF LACTOFERRIN RELATED PEPTIDES AND USES THEREOF
    Publication number: 20070142292
    Abstract: The present invention is directed to a composition consisting of a series of novel biologically active 33-mer peptides.
    Type: Application
    Filed: February 22, 2007
    Publication date: June 21, 2007
    Applicant: AGENNIX INCORPORATED
    Inventors: Atul Varadhachary, Peter Glynn, Karel Petrak, Jose Engelmayer
  • Composition of lactoferrin related peptides and uses thereof
    Publication number: 20060094082
    Abstract: The present invention is directed to a composition consisting of a series of novel biologically active 33-mer peptides.
    Type: Application
    Filed: October 26, 2005
    Publication date: May 4, 2006
    Applicant: AGENNIX INCORPORATED
    Inventors: Atul Varadhachary, Peter Glynn, Karel Petrak, Jose Engelmayer
  • Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease
    Patent number: 7026295
    Abstract: The present invention relates to methods of using lactoferrin (LF) to reduce circulating levels of cholesterol and vascular inflammation, in order to treat, prevent or reduce the incidence of atherosclerosis and cardiovascular disease.
    Type: Grant
    Filed: December 4, 2003
    Date of Patent: April 11, 2006
    Assignee: Agennix Incorporated
    Inventors: Atul Varadhachary, Peter Glynn, Yenyun Wang, Jose Engelmayer